Bio + Healthcare
Innovations at the intersection of technology and biology will drive major improvements in the quality of our health and the cost of healthcare.
What we do
We Invest in Digital Health and Novel Life Science Companies
Menlo Ventures invests at the intersection of bio and tech, with a differentiated approach in core thesis areas including therapeutic platforms, transformative technologies, digital health, and healthcare SaaS.
Today, AI can predict how proteins fold, design new drugs, act as an ambient scribe during doctor visits, and more, leading to better treatments, tools, and diagnostics—more quickly and cost-effectively than ever before.
Our Thinking
At Menlo Ventures, we believe many of the greatest innovations in healthcare and life sciences will result from multi-disciplinary efforts that combine the best of biology and technology.
Our Bio + Healthcare Companies
The founders we back don’t limit themselves to what is, but relentlessly pursue what could be. We invest in transformative, early-stage Bio + Healthcare companies that are improving and equalizing access to healthcare.
Benchling is a life sciences R&D cloud platform helping the next generation of scientists make breakthrough discoveries faster than ever before.
Milestones
-
2012 – Founded
-
2019 – Partnered, Series C
Leadership
Saji Wickramasekara
Co-Founder & CEO
Ashu Singhal
Co-Founder & President
Partners
Delfi is developing a revolutionary test for early detection of cancer using machine learning on DNA in the blood.
Milestones
-
2019 – Founded
-
2019 – Partnered, Seed
Partners
Encoded Therapeutics, a precision gene therapy company, is developing genomics-driven medicines that have the potential to transform the treatment paradigm for severe genetic disorders.
Milestones
-
2014 – Founded
-
2019 – Partnered, Series C
Partners
Gilead is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need.
Milestones
-
1987 – Founded
-
1987 – Incubated by Menlo Ventures
-
1992 – IPO; NASDAQ: GILD
Partners
PillPack is a full-service pharmacy that delivers a better, simpler experience through convenient packaging, modern technology, and personalized service.
Milestones
-
2013 – Founded
-
2015 – Partnered, Series C
-
2018 – Acquired by Amazon Partner
Partners
Pliant Therapeutics is focused on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Milestones
-
2015 – Founded
-
2018 – Partnered, Series B
-
2020 – IPO; NASDAQ: PLRX
Partners
Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.
Milestones
-
2013 – Founded
-
2017 – Partnered, Series B
-
2021 – IPO; NASDAQ: RXRX
Leadership
Chris Gibson
Founder & CEO
Partners
Explore more
Related Focus Areas
AI is breaking into every software category. That’s why we invest in early-stage companies, helping winners in these markets create massive economic and societal value.
The world we live in today is enhanced by technologies we might not have thought possible even 10 years ago, and there is so much still to come.
Menlo Ventures invests across four fintech categories: APIs, vertical banking, services for consumers and SMBs, and tools for the office of the CFO.
The shift to the cloud introduced software-as-a-service and created unprecedented opportunities for enterprise software companies.
